STOCK TITAN

Thermo Fisher Scientific, Inc. - TMO STOCK NEWS

Welcome to our dedicated page for Thermo Fisher Scientific news (Ticker: TMO), a resource for investors and traders seeking the latest updates and insights on Thermo Fisher Scientific stock.

Thermo Fisher Scientific, Inc. (TMO) is a global leader in providing science-based solutions, offering a wide range of products and services in the life sciences, analytical instruments, specialty diagnostics, and laboratory products sectors. The company's expansive portfolio includes scientific instruments, laboratory equipment, diagnostic consumables, and life science reagents, serving customers both in the United States and internationally.

Thermo Fisher operates through four distinct segments as of end-2023:

  • Analytical Technologies (17% of sales): This segment focuses on providing high-quality instruments and software solutions for various scientific applications.
  • Specialty Diagnostic Products (10% of sales): This segment specializes in offering diagnostic reagents and instruments for medical and research laboratories.
  • Life Science Solutions (23% of sales): This segment provides reagents, instruments, and consumables used in biological research and drug development.
  • Lab Products and Services (54% of sales): This is the largest segment, encompassing laboratory supplies, equipment, and contract research organization (CRO) services.

Thermo Fisher is continually expanding its offerings and capabilities through strategic partnerships, acquisitions, and technological innovation. The company's robust financial performance underscores its leadership in the industry, driven by consistent revenue growth, strong market presence, and a commitment to advancing scientific research and healthcare.

Recent achievements include technological advancements in analytical instruments, enhanced diagnostic solutions, and expanded biopharma services, reflecting Thermo Fisher's dedication to supporting life-saving research and diagnostic processes. Thermo Fisher remains committed to delivering high-quality products and services, fostering scientific breakthroughs, and maintaining its position at the forefront of scientific innovation.

Rhea-AI Summary

Thermo Fisher Scientific (NYSE: TMO) reported a 9% increase in third-quarter revenue to $9.33 billion, with GAAP diluted EPS at $4.79 and adjusted EPS rising 2% to $5.76. COVID-19 response revenue was $2.05 billion. The company raised its 2021 revenue guidance to $37.1 billion, projecting 15% growth, and adjusted EPS guidance to $23.37, indicating a 20% year-over-year growth. Major innovations included new products in oncology and biopharma, alongside expanding capacities in North Carolina and South Korea to support vaccine production.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.65%
Tags
none
-
Rhea-AI Summary

Thermo Fisher Scientific (TMO) released its 2020 Corporate Social Responsibility (CSR) report, highlighting significant commitments to environmental, social, and governance (ESG) efforts. Key achievements include producing over 700 million PCR-based COVID-19 tests and investing $1.3 billion in diverse-owned businesses. The report also showcases initiatives for colleague support, with 40% of leadership hires being women, a $30 million investment in STEM education, and a $25 million COVID-19 testing program for historically black colleges. The company is on track to achieve a 30% reduction in greenhouse gas emissions by 2030.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.1%
Tags
none
-
Rhea-AI Summary

Thermo Fisher Scientific (NYSE: TMO) has priced a $5.85 billion offering of senior notes, which includes $1 billion of 18-month floating rate notes, $1.35 billion of 0.797% senior notes, and $2.5 billion of 1.215% senior notes due in 2024. The offering is set to close on or about October 22, 2021. Proceeds will primarily finance the acquisition of PPD, Inc., with potential uses for general corporate purposes. Interest on floating rate notes will be paid quarterly, while fixed rate notes will pay semi-annually.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.28%
Tags
none
Rhea-AI Summary

Thermo Fisher Scientific (NYSE: TMO) announced its intention to offer USD-denominated senior notes to help fund its proposed acquisition of PPD, Inc. The notes will also support general corporate purposes, such as debt refinancing and working capital. The offering is led by joint book-running managers including Barclays, Morgan Stanley, and BofA Securities. This action follows an effective registration statement filed with the SEC. Investors should note the potential risks associated with capital market conditions and the acquisition timeline.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.69%
Tags
none
-
Rhea-AI Summary

Thermo Fisher Scientific Inc. (NYSE: TMO) will announce its third-quarter 2021 financial results on October 27, 2021, before the market opens. A conference call will follow at 8:30 a.m. EDT, where the company will discuss its performance and future outlook. Interested parties can listen via phone or through the company’s website. With an annual revenue of approximately $35 billion, Thermo Fisher is committed to supporting scientific advancement and improving global health.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.48%
Tags
-
Rhea-AI Summary

Thermo Fisher Scientific has priced an offering of €5.25 billion in euro-denominated senior notes through its wholly-owned subsidiary. The notes include €1.75 billion of 0.800% notes due 2030, €1.5 billion of 1.125% notes due 2033, €1.25 billion of 1.625% notes due 2041, and €750 million of 2.000% notes due 2051. Proceeds will fund the acquisition of PPD, Inc. The offering is expected to close around October 18, 2021, and is fully guaranteed by Thermo Fisher.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.37%
Tags
none
Rhea-AI Summary

Thermo Fisher Scientific (NYSE:TMO) has taken operational control of a new biologics manufacturing site in Lengnau, Switzerland, as part of its partnership with CSL Limited. This facility spans 1.5 million square feet and will enhance production capabilities with bioreactors up to 12,500L. Approximately 200 employees will join Thermo Fisher. Initially, the site will support CSL's Idelvion® production for hemophilia B, with plans for further expansion to other biopharma clients. This move strengthens Thermo Fisher's global biologics manufacturing network, including locations in the US, Netherlands, Australia, and China.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.24%
Tags
none
-
Rhea-AI Summary

Thermo Fisher Scientific (NYSE: TMO) announced its continued $7.5 million commitment for the 2021-2022 school year to support The Just Project, providing no-cost COVID-19 testing at over 60 historically black colleges and universities (HBCUs). The initiative aims to ensure campus safety amidst rising COVID-19 cases, having conducted over 50,000 tests last year with infection rates below 1%. Additionally, Thermo Fisher plans to hire more than 500 HBCU alumni over three years to promote diversity in its workforce.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.55%
Tags
covid-19
-
Rhea-AI Summary

Thermo Fisher Scientific Inc. (TMO) announced a $3 billion share repurchase authorization, effective immediately and with no expiration date. This new authorization replaces the previous one, which had $500 million remaining. The company's annual revenue stands at approximately $35 billion, emphasizing its position as a leader in serving science. The buyback aims to enhance shareholder value by reducing the number of shares outstanding, which can result in an increase in earnings per share (EPS).

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.25%
Tags
buyback
Rhea-AI Summary

Thermo Fisher Scientific (NYSE: TMO) will have its CEO, Marc N. Casper, present virtually at the JP Morgan 12th Annual U.S. All Stars Conference on September 22, 2021, at 9:00 a.m. EDT. This event showcases the company's commitment to advancing scientific research through innovative solutions. Thermo Fisher, with annual revenues of approximately $35 billion, serves a wide range of scientific needs globally.

Access the webcast via the Investors section of Thermo Fisher's website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.16%
Tags
conferences

FAQ

What is the current stock price of Thermo Fisher Scientific (TMO)?

The current stock price of Thermo Fisher Scientific (TMO) is $513.08 as of November 15, 2024.

What is the market cap of Thermo Fisher Scientific (TMO)?

The market cap of Thermo Fisher Scientific (TMO) is approximately 196.7B.

What does Thermo Fisher Scientific, Inc. specialize in?

Thermo Fisher Scientific specializes in life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services.

What are the main segments of Thermo Fisher Scientific?

The main segments are Analytical Technologies, Specialty Diagnostic Products, Life Science Solutions, and Lab Products and Services.

How much of Thermo Fisher's sales come from Lab Products and Services?

Lab Products and Services account for 54% of Thermo Fisher's sales.

Where does Thermo Fisher Scientific operate?

Thermo Fisher Scientific operates both in the United States and internationally.

What recent achievements has Thermo Fisher Scientific made?

Recent achievements include advancements in analytical instruments, enhanced diagnostic solutions, and expanded biopharma services.

What is Thermo Fisher Scientific's stock symbol?

The stock symbol for Thermo Fisher Scientific is TMO.

How does Thermo Fisher Scientific support scientific research?

Thermo Fisher supports scientific research by providing high-quality instruments, reagents, and consumables essential for biological research and drug development.

What types of products does Thermo Fisher Scientific offer?

Thermo Fisher offers scientific instruments, laboratory equipment, diagnostic consumables, and life science reagents.

What is Thermo Fisher's commitment to the healthcare industry?

Thermo Fisher is committed to advancing scientific research and healthcare by delivering high-quality products, fostering scientific breakthroughs, and supporting life-saving research and diagnostic processes.

What sets Thermo Fisher Scientific apart in its industry?

Thermo Fisher's leadership stems from its diverse portfolio, strategic partnerships, technological innovation, and consistent financial performance.

Thermo Fisher Scientific, Inc.

NYSE:TMO

TMO Rankings

TMO Stock Data

196.72B
382.50M
0.18%
91.37%
0.8%
Diagnostics & Research
Measuring & Controlling Devices, Nec
Link
United States of America
WALTHAM